Petmed Express Inc
NASDAQ:PETS
Intrinsic Value
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. [ Read More ]
The intrinsic value of one PETS stock under the Base Case scenario is 8.476 USD. Compared to the current market price of 4.085 USD, Petmed Express Inc is Undervalued by 52%.
Valuation Backtest
Petmed Express Inc
Run backtest to discover the historical profit from buying and selling PETS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Petmed Express Inc
Current Assets | 85.7m |
Cash & Short-Term Investments | 53.5m |
Receivables | 2.2m |
Other Current Assets | 30m |
Non-Current Assets | 73.6m |
PP&E | 28.8m |
Intangibles | 39.7m |
Other Non-Current Assets | 5.1m |
Current Liabilities | 40.7m |
Accounts Payable | 25.4m |
Accrued Liabilities | 11.7m |
Other Current Liabilities | 3.6m |
Non-Current Liabilities | 4.9m |
Other Non-Current Liabilities | 4.9m |
Earnings Waterfall
Petmed Express Inc
Revenue
|
270.5m
USD
|
Cost of Revenue
|
-195.3m
USD
|
Gross Profit
|
75.2m
USD
|
Operating Expenses
|
-85.7m
USD
|
Operating Income
|
-10.5m
USD
|
Other Expenses
|
4.4m
USD
|
Net Income
|
-6.1m
USD
|
Free Cash Flow Analysis
Petmed Express Inc
What is Free Cash Flow?
PETS Profitability Score
Profitability Due Diligence
Petmed Express Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Petmed Express Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
PETS Solvency Score
Solvency Due Diligence
Petmed Express Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Petmed Express Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PETS Price Targets Summary
Petmed Express Inc
According to Wall Street analysts, the average 1-year price target for PETS is 7.905 USD with a low forecast of 6.565 USD and a high forecast of 9.45 USD.
Ownership
PETS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PETS Price
Petmed Express Inc
Average Annual Return | 3.38% |
Standard Deviation of Annual Returns | 33.26% |
Max Drawdown | -91% |
Market Capitalization | 86.2m USD |
Shares Outstanding | 21 147 000 |
Percentage of Shares Shorted | 28.98% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 212 full-time employees. The company went IPO on 2000-04-06. The firm's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. The company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The firm's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Contact
IPO
Employees
Officers
The intrinsic value of one PETS stock under the Base Case scenario is 8.476 USD.
Compared to the current market price of 4.085 USD, Petmed Express Inc is Undervalued by 52%.